BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 32086762)

  • 1. Monitoring CD8a
    Kristensen LK; Christensen C; Alfsen MZ; Cold S; Nielsen CH; Kjaer A
    Mol Imaging Biol; 2020 Aug; 22(4):1021-1030. PubMed ID: 32086762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4
    Kristensen LK; Fröhlich C; Christensen C; Melander MC; Poulsen TT; Galler GR; Lantto J; Horak ID; Kragh M; Nielsen CH; Kjaer A
    Theranostics; 2019; 9(26):8221-8238. PubMed ID: 31754392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging Tumor-Infiltrating Lymphocytes in Brain Tumors with [
    Nagle VL; Henry KE; Hertz CAJ; Graham MS; Campos C; Parada LF; Pandit-Taskar N; Schietinger A; Mellinghoff IK; Lewis JS
    Clin Cancer Res; 2021 Apr; 27(7):1958-1966. PubMed ID: 33495310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a
    Clausen AS; Christensen C; Christensen E; Cold S; Kristensen LK; Hansen AE; Kjaer A
    EJNMMI Res; 2022 Sep; 12(1):62. PubMed ID: 36114433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site-Inhibited Factor VII.
    Nielsen CH; Jeppesen TE; Kristensen LK; Jensen MM; El Ali HH; Madsen J; Wiinberg B; Petersen LC; Kjaer A
    J Nucl Med; 2016 Jul; 57(7):1112-9. PubMed ID: 27013699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive Evaluation of CD20 Expression Using
    Kang L; Li C; Rosenkrans ZT; Engle JW; Wang R; Jiang D; Xu X; Cai W
    J Nucl Med; 2021 Mar; 62(3):372-378. PubMed ID: 32826320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
    Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM
    Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 64Cu-DOTA-anti-CTLA-4 mAb enabled PET visualization of CTLA-4 on the T-cell infiltrating tumor tissues.
    Higashikawa K; Yagi K; Watanabe K; Kamino S; Ueda M; Hiromura M; Enomoto S
    PLoS One; 2014; 9(11):e109866. PubMed ID: 25365349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of
    Jiang J; Zhang M; Li G; Liu T; Wan Y; Liu Z; Zhu H; Yang Z
    Bioorg Med Chem Lett; 2020 Feb; 30(4):126915. PubMed ID: 31926788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive Detection of HER2 Expression in Gastric Cancer by
    Guo X; Zhu H; Zhou N; Chen Z; Liu T; Liu F; Xu X; Jin H; Shen L; Gao J; Yang Z
    Mol Pharm; 2018 Nov; 15(11):5174-5182. PubMed ID: 30251865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8
    Seo JW; Tavaré R; Mahakian LM; Silvestrini MT; Tam S; Ingham ES; Salazar FB; Borowsky AD; Wu AM; Ferrara KW
    Clin Cancer Res; 2018 Oct; 24(20):4976-4987. PubMed ID: 29967252
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody and fragment-based PET imaging of CTLA-4+ T-cells in humanized mouse models.
    Ehlerding EB; Lee HJ; Jiang D; Ferreira CA; Zahm CD; Huang P; Engle JW; McNeel DG; Cai W
    Am J Cancer Res; 2019; 9(1):53-63. PubMed ID: 30755811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer.
    England CG; Jiang D; Hernandez R; Sun H; Valdovinos HF; Ehlerding EB; Engle JW; Yang Y; Huang P; Cai W
    Mol Pharm; 2017 Oct; 14(10):3239-3247. PubMed ID: 28825843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour models using a site-specifically labelled PD-L1 antibody.
    Christensen C; Kristensen LK; Alfsen MZ; Nielsen CH; Kjaer A
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1302-1313. PubMed ID: 31883023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Phosphatidylserine with a
    Perreault A; Richter S; Bergman C; Wuest M; Wuest F
    Mol Pharm; 2016 Oct; 13(10):3564-3577. PubMed ID: 27608290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab.
    Luo H; England CG; Graves SA; Sun H; Liu G; Nickles RJ; Cai W
    J Nucl Med; 2016 Feb; 57(2):285-90. PubMed ID: 26541778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and preclinical studies of
    Lam K; Chan C; Reilly RM
    MAbs; 2017 Jan; 9(1):154-164. PubMed ID: 27813707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-Animal PET/CT Imaging of Local and Systemic Immune Response Using
    Cao Q; Huang Q; Mohan C; Li C
    J Nucl Med; 2019 Sep; 60(9):1317-1324. PubMed ID: 30796172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and comparative evaluation of novel (64)Cu-labeled high affinity cell-specific peptides for positron emission tomography imaging of tumor vasculature.
    Merrill JR; Krajewski K; Yuan H; Frank JE; Lalush DS; Patterson C; Veleva AN
    Biomaterials; 2016 Apr; 84():241-249. PubMed ID: 26839954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer.
    Sun H; England CG; Hernandez R; Graves SA; Majewski RL; Kamkaew A; Jiang D; Barnhart TE; Yang Y; Cai W
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2169-2179. PubMed ID: 27342417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.